As the privacy and cybersecurity landscape evolves, drug and device makers face increased challenges in mergers and acquisitions. Privacy and cybersecurity risks directly impact both the value and potential liabilities of these deals. Below we briefly outline the current landscape,…
Source: www.jdsupra.com – Read more